Karen A. Lacourciere

Array ( [id] => 6639236 [patent_doc_number] => 20030212019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense modulation of cot oncogene expression' [patent_app_type] => new [patent_app_number] => 10/181873 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23148 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212019.pdf [firstpage_image] =>[orig_patent_app_number] => 10181873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403629 [patent_doc_number] => 20040023906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of phosphotyrosyl phosphatase activator expression' [patent_app_type] => new [patent_app_number] => 10/211179 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31638 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023906.pdf [firstpage_image] =>[orig_patent_app_number] => 10211179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843622 [patent_doc_number] => 20030148969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Antisense modulation of mucin 1, transmembrane expression' [patent_app_type] => new [patent_app_number] => 10/029517 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148969.pdf [firstpage_image] =>[orig_patent_app_number] => 10029517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908076 [patent_doc_number] => 20020142983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'MUC-1 antagonists and methods of treating immune disorders' [patent_app_type] => new [patent_app_number] => 09/984183 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14512 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142983.pdf [firstpage_image] =>[orig_patent_app_number] => 09984183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921687 [patent_doc_number] => 20020115120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Novel molecules of the HKID-1-related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 09/971791 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 34080 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115120.pdf [firstpage_image] =>[orig_patent_app_number] => 09971791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936572 [patent_doc_number] => 20020061843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Use of mCRP for delivery of materials into cells' [patent_app_type] => new [patent_app_number] => 09/971100 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7617 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061843.pdf [firstpage_image] =>[orig_patent_app_number] => 09971100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861641 [patent_doc_number] => 20030092649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Antisense modulation of vascular endothelial growth factor receptor-2 expression' [patent_app_type] => new [patent_app_number] => 09/967655 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28478 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092649.pdf [firstpage_image] =>[orig_patent_app_number] => 09967655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861642 [patent_doc_number] => 20030092650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Antisense modulation of sphingosine-1-phosphate lyase expression' [patent_app_type] => new [patent_app_number] => 09/967669 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25243 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092650.pdf [firstpage_image] =>[orig_patent_app_number] => 09967669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231195 [patent_doc_number] => 06692959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Antisense modulation of IL-1 receptor-associated kinase-4 expression' [patent_app_type] => B2 [patent_app_number] => 09/966451 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29433 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692959.pdf [firstpage_image] =>[orig_patent_app_number] => 09966451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861640 [patent_doc_number] => 20030092648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Antisense modulation of NAC expression' [patent_app_type] => new [patent_app_number] => 09/956712 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25288 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092648.pdf [firstpage_image] =>[orig_patent_app_number] => 09956712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433221 [patent_doc_number] => 20020127661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Nucleotide sequences coding for the sugA gene' [patent_app_type] => new [patent_app_number] => 09/951753 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7338 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127661.pdf [firstpage_image] =>[orig_patent_app_number] => 09951753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651266 [patent_doc_number] => 20030105036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense Inhibition of vascular endothelial growth factor receptor-1 expression' [patent_app_type] => new [patent_app_number] => 09/953318 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28026 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105036.pdf [firstpage_image] =>[orig_patent_app_number] => 09953318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411083 [patent_doc_number] => 06524854 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Antisense inhibition of PKA regulatory subunit RII alpha expression' [patent_app_type] => B1 [patent_app_number] => 09/954560 [patent_app_country] => US [patent_app_date] => 2001-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26708 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524854.pdf [firstpage_image] =>[orig_patent_app_number] => 09954560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792510 [patent_doc_number] => 20030087854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Antisense modulation of fibroblast growth factor receptor 3 expression' [patent_app_type] => new [patent_app_number] => 09/953047 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 209 [patent_figures_cnt] => 209 [patent_no_of_words] => 26224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087854.pdf [firstpage_image] =>[orig_patent_app_number] => 09953047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1324455 [patent_doc_number] => 06599502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-29 [patent_title] => 'Intracellular delivery vehicles' [patent_app_type] => B2 [patent_app_number] => 09/949109 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9714 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599502.pdf [firstpage_image] =>[orig_patent_app_number] => 09949109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779183 [patent_doc_number] => 20030050265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Antisense modulation of transforming growth factor-beta expression' [patent_app_type] => new [patent_app_number] => 09/948002 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19967 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050265.pdf [firstpage_image] =>[orig_patent_app_number] => 09948002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1197350 [patent_doc_number] => 06727355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Pharmaceutical composition for treatment of Duchenne muscular dystrophy' [patent_app_type] => B2 [patent_app_number] => 09/930251 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10869 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727355.pdf [firstpage_image] =>[orig_patent_app_number] => 09930251 [rel_patent_id] =>[rel_patent_doc_number] =>)